Article 9 (b)

(i)

assessing regulatory compliance;

(ii)

reviewing any pricing models used for risk purposes;

(iii)

specifying the market parameters to be used for calibration purposes, the way the calibration is to be done, and the frequency of update of the calibration;

(iv)

introducing any new methodologies for assessing market risk;

(v)

assessing the impacts on the acceptable level of risk, capital adequacy, and profitability;

(vi)

ensuring the availability of front, back and middle office resources and internal tools and expertise that allow for the understanding and monitoring of any associated new risks;

(vii)

specifying and proposing to the management body the restrictions in terms of maturities, underlying, counterparties, and internal limits for such new product;

(viii)

assessing the adequacy of the accounting schemes and ensuring that the internal reporting appropriately reflects the underlying risks;